Utah Medical Products, Inc.
UTMD
$64.51
-$0.48-0.74%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.28% | -18.65% | -23.83% | -19.68% | -20.87% |
| Total Depreciation and Amortization | 3.16% | 5.69% | -5.64% | -29.80% | -45.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 259.09% | 194.19% | 126.70% | 89.91% | 83.10% |
| Change in Net Operating Assets | 61.38% | 117.58% | 5.24% | -90.52% | -361.99% |
| Cash from Operations | -4.86% | -0.94% | -17.85% | -23.58% | -32.09% |
| Capital Expenditure | 19.13% | -61.30% | 12.86% | 18.38% | 36.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -100.00% | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | 100.00% | -- |
| Cash from Investing | 20.15% | -78.37% | 6.23% | 13.73% | 32.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -100.00% | 53.13% |
| Repurchase of Common Stock | 73.95% | 58.16% | -6.12% | -84.00% | -575.55% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 5.56% | 6.50% | 5.80% | 4.73% | 2.63% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 61.74% | 48.24% | -5.55% | -61.09% | -239.39% |
| Foreign Exchange rate Adjustments | 2,416.67% | 217.73% | -89.74% | 345.13% | 78.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 138.93% | 128.10% | -1,822.22% | -253.04% | -181.29% |